Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05367440
Title Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications

prostate cancer

Therapies

AZD5305 + Darolutamide

Abiraterone + AZD5305

AZD5305 + Enzalutamide

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Research Site Not yet recruiting Camperdown 2050 Australia Details
Research Site Not yet recruiting Darlinghurst 2010 Australia Details
Research Site Recruiting East Melbourne 3002 Australia Details
Research Site Not yet recruiting Melbourne 3000 Australia Details
Research Site Not yet recruiting St. Leonards 2065 Australia Details
Research Site Not yet recruiting Cambridge CB2 0QQ United Kingdom Details
Research Site Not yet recruiting Glasgow G12 0YN United Kingdom Details
Research Site Not yet recruiting Hampshire SO16 6YD United Kingdom Details
Research Site Not yet recruiting Manchester M20 4BX United Kingdom Details
Research Site Not yet recruiting Newcastle Upon Tyne NE7 7JA United Kingdom Details
Research Site Not yet recruiting Plymouth PL6 8DH United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field